"The record RISPERDAL CONSTA sales in our third quarter underscore the increasing importance of this medication in the marketplace," commented James Frates, ...
Risperdal Consta is the longer-lasting injectable version of Johnson & Johnson's schizophrenia drug Risperdal (risperidone). The drug is approved in over 75 ...
Alkermes is a leader in developing long-acting medications and has an established portfolio of CNS products, including RISPERDAL(R) CONSTA(R), VIVITROL(R), ...
Alkermes Inc. (ALKS, $11.18, +$0.66, +6.27%) topped expectations for its fiscal third quarter on strong sales of its Risperdal Consta co-marketed treatment ...
... including Risperdal, an anti-psychotic medication that was recently at the center of a Department of Justice complaint. The drug company also faced a ...
Financial News USA (press release) - Feb 7, 2010
He said sales of schizophrenia drug Risperdal Consta are improving, while the company could soon get marketing approval for its diabetes drug exenatide LAR, ...
Risperdal is used principally for the treatment of schizophrenia and bipolar disorder. Doping the elderly into placidity is an off-label use of the drug, ...
Quarterly revenues of $44.2 million, driven by record manufacturing and royalty revenues from RISPERDAL® CONSTA®. Worldwide sales of RISPERDAL CONSTA by ...
Zyprexa faced new competition last year after lower- priced generic copies of Johnson & Johnson's Risperdal, a rival schizophrenia treatment, went on sale. ...
Email this story